Illumina, Inc. (ILMN) vs Natera, Inc. (NTRA)
- Illumina, Inc. ILMN 262.03 −2.20%
- Natera, Inc. NTRA 391.98 −3.16%
Illumina, Inc. and Natera, Inc. are both Diagnostics & Research companies. Natera, Inc. is the larger, with a market value of $58.4B against $40.5B — 1.4× the size. Natera, Inc. has negative trailing earnings, so its P/E is not meaningful; Illumina, Inc. trades at 48.4×. Natera, Inc. grew revenue faster over the last twelve months: 37.8% against 4.88%. Illumina, Inc. has the higher net margin (18.4% vs −7.11%) and the higher return on invested capital (17.5% vs −22.3%). Across the 20 metrics below, Illumina, Inc. leads on 16 and Natera, Inc. on 4.
Valuation
Profitability
| Metric | ILMN | NTRA | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 66.39% | 65.23% | 50.89% |
| Operating margin | 19.65% | (10.70%) | (8.57%) |
| Net margin | 18.36% | (7.11%) | (6.37%) |
| Free cash flow margin | 20.72% | 3.11% | 0.00% |
| Return on equity | 32.38% | (12.54%) | (2.92%) |
| Return on assets | 12.95% | (8.71%) | (6.71%) |
| Return on invested capital | 17.46% | (22.34%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack